HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 294/4/G892    most recent 00575.2007v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (4) Citing Articles via Google Scholar Google Scholar Articles by You, M. Articles by Ness, G. C. Search for Related Content PubMed PubMed Citation Articles by You, M. Articles by Ness, G. C.

LIVER AND BILIARY TRACT

Involvement of mammalian sirtuin 1 in the action of ethanol in the liver

Departments of ¹Molecular Pharmacology and Physiology and ²Molecular Medicine, University of South Florida Health Sciences Center, Tampa, Florida

Submitted 13 December 2007 ; accepted in final form 29 January 2008

Chronic ethanol feeding causes liver steatosis in animal models by upregulating the sterol regulatory element-binding protein 1 (SREBP-1), which subsequently increases the synthesis of hepatic lipid. SREBP-1 activity is regulated by reversible acetylation at specific lysine residues. The present study tests the hypothesis that activation of SREBP-1 by ethanol may be mediated by mammalian sirtuin 1 (SIRT1), a NAD⁺-dependent class III protein deacetylase. The effects of ethanol on SIRT1 were determined in cultured rat hepatoma cells and in the livers of ethanol-fed mice. In rat H4IIEC3 cells, we observed that ethanol exposure induced SREBP-1c lysine acetylation and SREBP-1c transcriptional activity. The effect of ethanol was abolished by expression of wild-type SIRT1 or by treatment with resveratrol, a known potent SIRT1 agonist. Conversely, knocking down SIRT1 by the small silencing SIRT1 plasmid SIRT1shRNA or expression of a SIRT1 mutant, SIRT1(H363Y), did not negate the ethanol effect. These findings suggest that the effect of ethanol on SREBP-1 is mediated, at least in part, through SIRT1 inhibition. Consistent with the in vitro findings, chronic ethanol feeding substantially downregulated hepatic SIRT1 in mice. Inhibition of hepatic SIRT1 activity was associated with an increase in the acetylated active nuclear form of SREBP-1c in the livers of ethanol-fed mice. Our results indicate an essential role for SIRT1 in mediating the effects of ethanol on SREBP-1 and hepatic lipid metabolism, as well as the development of alcoholic fatty liver. Hence, SIRT1 may represent a novel therapeutic target for treatment of human alcoholic fatty liver disease.

alcoholic liver steatosis; lipid metabolism; acetylation; sterol regulatory element-binding protein-1c; peroxisome proliferator-activated receptor- coactivator-1

This article has been cited by other articles:

				M. You and C. Q. Rogers Adiponectin: A Key Adipokine in Alcoholic Fatty Liver Exp Biol Med, August 1, 2009; 234(8): 850 - 859. [Abstract] [Full Text] [PDF]

				Z. Shen, J. M. Ajmo, C. Q. Rogers, X. Liang, L. Le, M. M. Murr, Y. Peng, and M. You Role of SIRT1 in regulation of LPS- or two ethanol metabolites-induced TNF-{alpha} production in cultured macrophage cell lines Am J Physiol Gastrointest Liver Physiol, May 1, 2009; 296(5): G1047 - G1053. [Abstract] [Full Text] [PDF]

				J. M. Ajmo, X. Liang, C. Q. Rogers, B. Pennock, and M. You Resveratrol alleviates alcoholic fatty liver in mice Am J Physiol Gastrointest Liver Physiol, October 1, 2008; 295(4): G833 - G842. [Abstract] [Full Text] [PDF]